ClinicalTrials.gg
CompletedNCT06947798Updated Oct 26, 2026

The Effect of Motivational Interviewing on Anthropometric Measurements, Eating Attitudes, and Cardiometabolic Index in Overweight and Obese Patients

An interventional study of motivational interviewing and Diet in Motivational Interviewing, Cardiometabolic Index and Obesity, sponsored by Saltuklu Aile Sağlığı Merkezi. Completed at 1 site in Turkey (Türkiye). Open to participants aged 20 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-26.

Sponsored by Saltuklu Aile Sağlığı Merkezi · Not applicable, Interventional, and Treatment

How we know

Updated Oct 26, 2026Now CompletedFirst site in Turkey (Türkiye)+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
20 Years to 40 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 353 studies in Obesity with a site in Turkey — 73 open to participants now, 90 under way, 16 of them phase 3. Obesity · Turkey.

Enrollment
73rd of 192
80 · median 64
Started
2025
with 53 others
No phase
161 of 353
29 open now
Registered
204th of 353
by date

Among the 353 studies in Obesity with a site in Turkey, this one is the 73rd largest by enrollment of the 192 interventional ones that give a count, is one of 54 that started in 2025, is one of 161 with no phase, and was the 204th registered.

Obesity

11,564 studies on the registry are indexed under Obesity; 2,063 are open to participants now.

Browse Obesity studies →

Open to participants now

73 of the 353 studies in Obesity with a site in Turkey are open now. Recruiting first, the newest first:

68 more — sign in →

All 73 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 1,352 Obesity studies recruiting now, 382 (28%) set no upper age limit and 867 (64%) stop at 75 or younger; 169 take children under 18; 491 take healthy volunteers.

This study: 20 Years to 40 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 353 studies in Obesity with a site in Turkey, or all of them as a file.
02

Study summary

The Effect of Motivational Interviewing on Anthropometric Measurements, Eating Attitudes, and Cardiometabolic Index in Overweight and Obese Patients

Read the detailed description

Participants were randomly assigned into two groups-an Intervention Group (n = 40) and a Control Group (n = 40)-using block randomization through the website "random.org." Data were collected using a Personal Information Form, the Eating Behavior Disorder Scale, Anthropometric Measurements (body weight, body mass index, waist circumference, waist/hip ratio), and the Cardiometabolic Index. Both groups received routine recommendations, which included a daily caloric restriction of 500 kcal and moderate-intensity aerobic exercise for 30 minutes, five days a week.Motivational interviewing was administered to the intervention group through individual sessions, held once every two weeks, for a total of four sessions, each lasting 15 minutes. The interviews were conducted in the Education Room of the Saltuklu Family Health Center. After the motivational interviewing intervention was completed, post-tests (Eating Behavior Disorder Scale, Anthropometric Measurements, and Cardiometabolic Index) were administered to both groups. All participants were followed for a period of three months.

03

Conditions studied

  • Motivational Interviewing
  • Cardiometabolic Index
  • Obesity
  • Overweight (BMI > 25)
  • Anthropometric Measurements
  • Eating Behavior Disorders
04

Who can participate

Ages eligible
20 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • (BMI) in the range of 25 to 34.9 kg/m² was considered as an inclusion criterion
  • Being between 20 and 40 years of age (corresponding to the young adulthood period according to Erikson)

    -- Participants were required to be registered with the Saltuklu Family Health Center.

  • Willingness to participate in the study and provision of were required

Exclusion criteria

Exclusion Criteria:

  • Current use of medications known to induce weight gain or loss
  • Presence of a diagnosed chronic illness
  • Pregnancy or being in the lactation period."
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
80 participants (actual)

Study arms

  • Active comparator
    experimental group

    In addition to the procedures applied to the control group, the experimental group was also subjected to motivational interviewing

    Behavioral: motivational interviewing · Other: Diet · Behavioral: Physical exercise

  • Active comparator
    Control

    The control group received a dietary intervention involving a daily caloric restriction and was instructed to engage in moderate-intensity aerobic exercise for 30 minutes, five times per week.

    Other: Diet · Behavioral: Physical exercise

Interventions

  • Behavioralmotivational interviewing

    motivational interviewing four times

  • OtherDiet

    A calorie-restricted diet was implemented in both the intervention and control groups.

  • BehavioralPhysical exercise

    A moderate-intensity aerobic exercise program, consisting of 30-minute sessions five days per week, was implemented in both groups

06

What researchers measure

Primary outcomes

  1. CMI

    Cardiometabolic index

    Time frame: three months

07

Study locations

1 site
  • Saltuklu Family Health Center
    Erzurum, Saltuklu 25100, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from May 2025 to primary completion in Aug 2025, 3 months.

Of 3,697 non-industry interventional studies with no phase under Obesity, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's 3 months is below that.

Counting every sponsor, half of 3,861 studies reached it within 22 months; a quarter within 9 and three quarters within 42.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 17, 2025
First posted
Apr 27, 2025
StartActual
May 20, 2025
Primary completionActual
Aug 20, 2025
CompletionActual
Aug 20, 2025
Last update
Oct 26, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Completed
changed Oct 26, 2026
Sites
1 site added — first site in Turkey (Türkiye)
Show site
  • Saltuklu Family Health Center · Erzurum, Turkey (Türkiye)
Oct 26, 2026
Show all 1 update
  1. Oct 26, 2026
    Not yet recruiting→Completed
    1 site added — first site in Turkey (Türkiye)
    Show site
    • Saltuklu Family Health Center · Erzurum, Turkey (Türkiye)
    + 4 other changes: index terms, date precision, criteria formatting and contact details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06947798
Lead sponsor
Saltuklu Aile Sağlığı Merkezi
Responsible party
ORHUN DÖNMEZ (Principal Investigator, Saltuklu Aile Sağlığı Merkezi) — Principal investigator
First posted
Apr 27, 2025
Start date
May 20, 2025
Primary completion
Aug 20, 2025
Completion
Aug 20, 2025
Last update
Oct 26, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion